Article
Boric acid as a protector against paclitaxel genotoxicity.
19 Mar 2010
Abstract excerpt
Paclitaxel (PAC) is an anticancer drug used for treatments of breast, ovarian and lung cancers. However, little data is available in the literature on its potential genotoxicity on healthy human cells. On the other hand, boron deficiency and supplementation exert important biological effects in human and animal tissues. The biological effects of dietary boron are defined, but its interaction with PAC is not known...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
